Viewing Study NCT01611857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:06 PM
Ignite Modification Date: 2026-02-08 @ 4:10 PM
Study NCT ID: NCT01611857
Status: COMPLETED
Last Update Posted: 2016-11-23
First Post: 2012-06-01
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach
Sponsor: SCRI Development Innovations, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Solid Tumour View
None Gastroesophageal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced solid tumors View
None First-Line Metastatic GE cancer View
None c-Met Inhibitor View
None Tivantinib View
None FOLFOX View